Alyeska Investment Group, L.P. - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 83 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$1,409,316
-18.3%
445,9860.0%0.01%
-23.1%
Q2 2023$1,725,966
+30.8%
445,986
-6.4%
0.01%
+8.3%
Q1 2023$1,319,708
+53.9%
476,4290.0%0.01%
+33.3%
Q4 2022$857,572
-15.1%
476,4290.0%0.01%
-25.0%
Q3 2022$1,010,000
-24.3%
476,429
-3.9%
0.01%
-20.0%
Q2 2022$1,334,000
-38.0%
495,9860.0%0.02%
-37.5%
Q1 2022$2,153,000
-16.2%
495,9860.0%0.02%
-20.0%
Q4 2021$2,569,000
-15.6%
495,9860.0%0.03%
-21.1%
Q3 2021$3,045,000
-77.5%
495,986
-65.0%
0.04%
-75.6%
Q2 2021$13,520,0001,415,6390.16%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$47,848,0007.75%
AMAZON COM INC 1,457,055$14,716,0003.85%
Ally Bridge Group (NY) LLC 1,500,000$15,150,0003.76%
Affinity Asset Advisors, LLC 900,000$9,090,0003.25%
Bain Capital Life Sciences Investors, LLC 2,000,000$20,200,0001.32%
Perceptive Advisors 17,822,302$180,004,0001.17%
SPHERA FUNDS MANAGEMENT LTD. 800,000$8,080,0000.55%
HILLMAN CO 200,000$2,020,0000.52%
RA Capital Management 2,471,430$24,961,0000.40%
Nantahala Capital Management 1,190,810$12,027,0000.34%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders